An earlier AHIP report estimated that the direct costs of COVID-19 treatment for 2020 and 2021 would be between $56 and $556 billion depending upon rate of infection.
Revised reporting commissioned by America's Health Insurance Plans projects lowered costs estimates for hospitalizations associated with COVID-19, even as the per patient costs for those admissions rise.
The report, conducted by Wakely Consulting Group, updates its March 30 report to reflect new data on the cost of the pandemic, utilization of healthcare and the effect of deferred treatment. The earlier report estimated that the direct costs of COVID-19 treatment for 2020 and 2021 would be between $56 billion and $556 billion depending upon rate of infection.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Greg Land
Greg Land covers topics including verdicts and settlements and insurance-related litigation for the Daily Report in Atlanta.
